Table of contents

Electronic pages

• Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials (11 June, 2019) Free

  Young Ho Lee, Gwan Gyu Song
• Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song (4 July, 2019) Free

  Wenhui Xie, Shiyu Xiao, Zhuoli Zhang
• Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA (22 June, 2019) Free

  Xanthe ME Matthijssen, Tom WJ Huizinga, Ellis Niemantsverdriet, Annette HM van der Helm-van Mil
• Mortality has improved in RA, but we must remain vigilant. Response to: ‘Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA’ by Matthijssen et al

  (8 July, 2019) Free

  Pomme B M Poppelaars, Lilian H D van Tuyl, Maarten Boers
• Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand?’ (21 June, 2019) Free

  Rikard Holmdahl
• Response to: ‘Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand’’ by Holmdahl (3 July, 2019) Free

  René Toes, David S Pisetsky
• On using machine learning algorithms to define clinically meaningful patient subgroups (21 June, 2019) Free

  Iago Pinal-Fernandez, Andrew Lee Mammen
• On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: ‘On using machine learning algorithms to define clinical meaningful patient subgroups’ by Pinal-Fernandez and Mammen (24 July, 2019) Free

  Alain Meyer, Lionel Spielmann, François Séverac
• Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen (20 July, 2019) Free

  Olivier Benveniste, Yves Allenbach, Benjamin Granger
• Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (5 June, 2019) Free

  Íñigo Rua Figueroa, Celia Erausquin
• Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin (3 July, 2019) Free

  Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
• Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine (5 June, 2019) Free

  Martin Michaud, Florian Catros, Sophie Ancellin, Francis Gaches
• Response to: ‘Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine’ by Michaud et al

  (11 July, 2019) Free

  Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
• Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome (8 June, 2019) Free

  Lucas L van den Hoogen, Maarten van der Linden, Linde Meyaard, Ruth D E Fritsch-Stork, Joel A van Roon, Timothy RDJ Radstake
• Response to: ‘Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome’ by van den Hoogen et al

  (4 July, 2019) Free

  Mariana J Kaplan, Kerry A Casey
• Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome? (12 June, 2019) Free

  Marion Couderc, Anne Tournadre, Sylvain Mathieu, Bruno Pereira, Martin Soubrier, Jean Jacques Dubost
• Sicca: an important manifestation of damage in systemic sclerosis (SSc) and SSc-overlap syndromes. Response to ‘Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome?’ by Coudrec et al

  (12 June, 2019) Free

  Mandana Nikpour
• Correction: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

  (14 September, 2020)